Our long term goal is to understand the mechanisms that control the growth, differentiation, and regeneration of liver. Epidermal growth factor (EGF) and its homologs are arguably the most thoroughly-studied growth factors in the control of liver growth, regeneration, and carcinogenesis, but we now know that signaling through the EGF receptor (EGFr) involves its interaction with a family of related receptors, the ErbB proteins. This study focuses on the role played by the ErbB receptors as regulators of growth and differentiation in liver. ErbB interactions have been studied almost exclusively in transformed or genetically altered cells in culture; their relevance to normal biology outside of the central nervous system and cancer cells has been unclear. We believe this proposal to represent a major conceptual reassessment in how EGF and its related growth factors function in one of its most prominent target tissues. We have documented extensive interactions between the EGFr and ErbB2 and ErbB3, but while the EGFr and ErbB3 are continuously expressed during liver development, the hepatic expression of ErbB2 is extinguished postnatally.
The aims of this proposal are to: 1. Define the developmental role of ErbB2 in designating the proliferative or differentiative phenotype of fetal liver; 2. Delineate the ErbB signaling mechanisms that distinguish fetal from adult liver; and 3. To establish the role of ErbB signaling in liver regeneration. Progress toward these aims will improve our understanding of how EGF- like molecules signal in a normal tissue, how the liver differentiates into its adult functional form, and the role of these potent mitogens in regulating the dramatic restoration of liver grwoth during regeneration. Liver regeneration is a paradigm for other conditions of normal or altered growth regulation, including tissue hypertrophy, wound healing, cancer, and possibly even normal childhood growth. In addition to elucidating mechanisms of growth control in the liver, our studies may ultimately aid in the generation of mature hepatocytes from undifferentiated precursor cells for transplantation and for generation of artificial livers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK053804-01
Application #
2563178
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1998-07-10
Project End
2001-05-31
Budget Start
1998-07-10
Budget End
1999-05-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Scheving, Lawrence A; Zhang, Xiuqi; Threadgill, David W et al. (2016) Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol 311:G807-G816
Scheving, Lawrence A; Zhang, Xiuqi; Stevenson, Mary C et al. (2015) Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis. Am J Physiol Gastrointest Liver Physiol 309:G942-54
Scheving, Lawrence A; Zhang, Xiuqi; Stevenson, Mary C et al. (2015) Loss of hepatocyte EGFR has no effect alone but exacerbates carbon tetrachloride-induced liver injury and impairs regeneration in hepatocyte Met-deficient mice. Am J Physiol Gastrointest Liver Physiol 308:G364-77
Scheving, Lawrence A; Zhang, Xiuqi; Garcia, Oscar A et al. (2014) Epidermal growth factor receptor plays a role in the regulation of liver and plasma lipid levels in adult male mice. Am J Physiol Gastrointest Liver Physiol 306:G370-81
Onuma, Hiroshi; Oeser, James K; Nelson, Bryce A et al. (2009) Insulin and epidermal growth factor suppress basal glucose-6-phosphatase catalytic subunit gene transcription through overlapping but distinct mechanisms. Biochem J 417:611-20
Myers, Timothy J; Brennaman, Leann H; Stevenson, Mary et al. (2009) Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-alpha shedding. Mol Biol Cell 20:5236-49
Scheving, Lawrence A; Buchanan, Renee; Krause, Michael A et al. (2007) Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes. Am J Physiol Gastrointest Liver Physiol 293:G552-9
Scheving, Lawrence A; Russell, William E (2006) Beta-catenin in the liver: an integrator of proliferation and metabolism? Gastroenterology 131:1641-3
Scheving, Lawrence A; Zhang, Linda; Stevenson, Mary C et al. (2006) The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling. Am J Physiol Gastrointest Liver Physiol 291:G16-25
Romero-Gallo, Judith; Sozmen, Elif G; Chytil, Anna et al. (2005) Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Oncogene 24:3028-41

Showing the most recent 10 out of 18 publications